Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 52 results.
User Information
Export Records
  1. 1.   The protein kinase MAP3K19 phosphorylates MAP2Ks and thereby activates ERK and JNK kinases and increases viability of KRAS-mutant lung cancer cells
  2. Hoang, Van T.; Nyswaner,Katherine; Torres-Ayuso,Pedro; Brognard,John
  3. JOURNAL OF BIOLOGICAL CHEMISTRY. 2020, JUN 19; 295(25): 8470-8479.
  1. 2.   Reduced brain cell proliferation following somatic injury is buffered by social interaction in electric fish, Apteronotus leptorhynchus
  2. Dunlap, Kent D; Vergara, Margarita M; Corbo,Joshua
  3. Developmental neurobiology. 2020, JUN 12;
  1. 3.   The Proteasome Ubiquitin Receptor hRpn13 and Its Interacting Deubiquitinating Enzyme Uch37 Are Required for Proper Cell Cycle Progression
  2. Randles, L.; Anchoori, R. K.; Roden, R. B.; Walters, K. J.
  3. The Journal of biological chemistry. 2016, 15-Apr; 291(16): 8773-83.
  1. 4.   Plumbagin, a naphthaquinone derivative induces apoptosis in BRCA 1/2 defective castrate resistant prostate cancer cells as well as prostate cancer stem-like cells
  2. Reshma, R. S.; Sreelatha, K. H.; Somasundaram, V.; Satheesh Kumar, S.; Nadhan, R.; Nair, R. S.; Srinivas, P.
  3. Pharmacological Research. 2016, Mar; 105: 134-45.
  1. 5.   14-3-3 Proteins: Diverse functions in cell proliferation and cancer progression
  2. Freeman, A. K.; Morrison, D. K.
  3. Seminars in Cell & Developmental Biology. 2011, Sep; 22(7): 681-687.
  1. 6.   Polo-box domain: a versatile mediator of polo-like kinase function
  2. Park, J. E.; Soung, N. K.; Johmura, Y.; Kang, Y. H.; Liao, C.; Lee, K. H.; Park, C. H.; Nicklaus, M. C.; Lee, K. S.
  3. Cellular and Molecular Life Sciences. 2010, Jun; 67(12): 1957-1970.
  1. 7.   Short and sweet: evolution of a small glycopeptide from a bladder disorder to an anticancer lead
  2. Barchi, J. J., Jr.; Kaczmarek, P.
  3. Molecular Interventions. 2009, Feb; 9(1): 14-7.
  1. 8.   Id1 immortalizes hematopoietic progenitors in vitro and promotes a myeloproliferative disease in vivo
  2. Suh, H. C.; Leeanansaksiri, W.; Ji, M.; Klarmann, K. D.; Renn, K.; Gooya, J.; Smith, D.; McNiece, I.; Lugthart, S.; Valk, P. J.; Delwel, R.; Keller, J. R.
  3. Oncogene. 2008, Sep 18; 27(42): 5612-5623.
  1. 9.   IL-15 induces C4+ effector memory T cell production and tissue emigration in nonhuman primates
  2. Picker, L. J.; Reed-Inderbitzin, E. F.; Hagen, S. I.; Edgar, J. B.; Hansen, S. G.; Legasse, A.; Planer, S.; Piatak, M.; Lifson, J. D.; Maino, V. C.; Axthelm, M. K.; Villinger, F.
  3. Journal of Clinical Investigation. 2006, JUN; 116(6): 1514-1524.
  1. 10.   Stop and go - Anti-proliferative and mitogenic functions of the transcription factor C/EBP beta
  2. Sebastian, T.; Johnson, P. F.
  3. Cell Cycle. 2006, May; 5(9): 953-957.
  1. 11.   Generation and characterization of telomere length maintenance in tankyrase 2-deficient mice
  2. Chiang, Y. J.; Nguyen, M. L.; Gurunathan, S.; Kaminker, P.; Tessarollo, L.; Campisi, J.; Hodes, R. J.
  3. Molecular and Cellular Biology. 2006, MAR; 26(6): 2037-2043.
  1. 12.   C/EBP beta is a critical mediator of steroid hormone-regulated cell proliferation and differentiation in the uterine epithelium and stroma
  2. Mantena, S. R.; Kannan, A.; Cheon, Y. P.; Li, Q. X.; Johnson, P. F.; Bagchi, I. C.; Bagchi, M. K.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2006, FEB 7; 103(6): 1870-1875.
  1. 13.   Innate immune dysfunction in HIV infection: Effect of HIV envelope-NK cell interactions
  2. Kottilil, S.; Shin, K.; Jackson, J. O.; Reitano, K. N.; O'Shea, M. A.; Yang, J.; Hallahan, C. W.; Lempicki, R.; Arthos, J.; Fauci, A. S.
  3. Journal of Immunology. 2006, JAN 15; 176(2): 1107-1114.
  1. 14.   An imprinted locus epistatically influences Nstr1 and Nstr2 to control resistance to nerve sheath tumors in a neurofibromatosis type 1 mouse model
  2. Reilly, K. M.; Broman, K. W.; Bronson, R. T.; Tsang, S.; Loisel, D. A.; Christy, E. S.; Sun, Z. H.; Diehl, J.; Munroe, D. J.; Tuskan, R. G.
  3. Cancer Research. 2006, JAN 1; 66(1): 62-68.
  1. 15.   The immunopharmacological properties of transforming growth factor beta
  2. Le, Y. Y.; Yu, X. J.; Ruan, L. F.; Wang, O. M.; Qi, D. F.; Zhu, J. J.; Lu, X. F.; Kong, Y.; Cai, K.; Pang, S. S.; Shi, X. L.; Wang, J. M.
  3. International Immunopharmacology. 2005, DEC; 5(13-14): 1771-1782.
  1. 16.   FGFR1 function at the earliest stages of mouse limb development plays an indispensable role in subsequent autopod morphogenesis
  2. Li, C. L.; Xu, X. L.; Nelson, D. K.; Williams, T.; Kuehn, M. R.; Deng, C. X.
  3. Development. 2005, NOV; 132(21): 4755-4764.
  1. 17.   The p270 (ARID1A/SMARCF1) subunit of mammalian SWI/SNF-related complexes is essential for normal cell cycle arrest
  2. Nagl, N. G.; Patsialou, A.; Haines, D. S.; Dallas, P. B.; Beck, G. R.; Moran, E.
  3. Cancer Research. 2005, OCT 15; 65(20): 9236-9244.
  1. 18.   Expression of hypoxia-inducible carbonic anhydrases in brain tumors
  2. Proescholdt, M. A.; Mayer, C.; Kubitza, M.; Schubert, T.; Liao, S. Y.; Stanbridge, E. J.; Ivanov, S.; Oldfield, E. H.; Brawanski, A.; Merrill, M. J.
  3. Neuro-Oncology. 2005, OCT; 7(4): 465-475.
  1. 19.   Activation of the Jun N-terminal kinase pathway by friend spleen focus-forming virus and its role in the growth and survival of friend virus-induced erythroleukemia cells
  2. Nishigaki, K.; Hanson, C.; Thompson, D.; Yugawa, T.; Ruscetti, S.
  3. Journal of Virology. 2005, OCT; 79(20): 12752-12762.
  1. 20.   Effect of EBV LMP1 targeted DNAzymes on cell proliferation and apoptosis
  2. Lu, Z. X.; Ye, M.; Yan, G. R.; Li, Q.; Tang, M.; Lee, L. M.; Sun, L. Q.; Cao, Y.
  3. Cancer Gene Therapy. 2005, JUL; 12(7): 647-654.
  1. 21.   Formylpeptide receptor FPR and the rapid growth of malignant human gliomas
  2. Zhou, Y.; Bian, X. W.; Le, Y. Y.; Gong, W. H.; Hu, J. Y.; Zhang, X.; Wang, L. H.; Iribarren, P.; Salcedo, R.; Howard, O. M. Z.; Farrar, W.; Wang, J. M.
  3. Journal of the National Cancer Institute. 2005, JUN 1; 97(11): 823-835.
  1. 22.   Microarray analysis of altered gene expression in murine fibroblasts transformed by nickel(II) to nickel(II)-resistant malignant phenotype
  2. Kowara, R.; Karaczyn, A.; Cheng, R. Y. S.; Salnikow, K.; Kasprzak, K. S.
  3. Toxicology and Applied Pharmacology. 2005, MAY 15; 205(1): 1-10.
  1. 23.   Inhibition of prolidase activity by nickel causes decreased growth of proline auxotrophic CHO cells
  2. Miltylk, W.; Surazynski, A.; Kasprzak, K. S.; Fivash, M. J.; Buzard, G. S.; Phang, J. M.
  3. Journal of Cellular Biochemistry. 2005, APR 15; 94(6): 1210-1217.
  1. 24.   Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappa B/p65 DNA binding
  2. Hu, J.; Colburn, N. H.
  3. Molecular Cancer Research. 2005, FEB; 3(2): 100-109.
  1. 25.   Induction of human T cell leukemia virus type I receptors on quiescent naive T lymphocytes by TGF-beta(1,2)
  2. Jones, K. S.; Akel, S.; Petrow-Sadowski, C.; Huang, Y.; Bertolette, D. C.; Ruscetti, F. W.
  3. Journal of Immunology. 2005 174(7): 4262-4270.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel